FindTrial
Sign In

The clinical effect of dydrogesterone used for ovarian stimulation in normal-ovulatory women:a randomized controlled dose-finding study of 10 mg versus 20 mg

The clinical effect of dydrogesterone used for ovarian stimulation in normal-ovulatory women:a randomized controlled dose-finding study of 10 mg versus 20 mg

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094539
Enrollment
Unknown
Registered
2024-12-24
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Interventions

Control group:Dydrogesterone 20mg/d
Experimental group:Dydrogesterone 10mg/d

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 35 Years

Inclusion criteria

Inclusion criteria: 1.Infertility women aged under 35 years; 2.BMI:18-25 kg/m2; 3.Normalovulatory patients with a 'freeze-all' policy.

Exclusion criteria

Exclusion criteria: 1. Documented IVF failure cycles more than two times; 2. Documented cycles with no oocyte retrieved; 3. Endometriosis grade 3 or higher; 4. Clinically significant systemic disease such as renal failure; 5. Cycles with preimplantation genetic screening.

Design outcomes

Primary

MeasureTime frame
The number of oocytes retrieved;—

Countries

China

Contacts

Public ContactYonglun Fu

Shanghai First Maternity and Infant Hospital

fuyonglunivf@163.com+86 139 1754 7302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026